跳至主要内容
临床试验/CTRI/2024/11/077317
CTRI/2024/11/077317招募中2 期

A Pilot Exploratory Clinical Study To Evaluate the efficacy of local application of Arthocan-J100 Lep Powder in Rheumatoid Arthritis (Aamvata)

Sudhatatva Pharmacy1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年12月2日最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
30
试验地点
1
主要终点
Primary Outcome-Reduction in Sandhi shotha (inflammation of joint) by using the measuring tape before and after treatment with Local Application ArthoCan-J100 Lep Powder.

研究概览

简要总结

It is a Pilot Explanatory Clinical Study to evaluate the efficacy of local application of Arthocan J100 lep Powder in patients with Rheumatoid Arthritis(Amavata)

Study design is a single arm clinical study.Total 30 patients will be enrolled.Assessment of patients on 1st and 14th day.Study duration will be 6 months

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
30.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 1.Patients having Inflammation of joints (Sandhi shotha) 2.Joint pain (Sandhi shool) 3.Restriction of joint movements (Sandhigraha) 4.Tenderness (Sparsha asahatva).

排除标准

  • 1.Known case of Uncontrolled Diabetes Mellitus.
  • 2.Known case of Vatarakta and Sandhigata vata.
  • 3.Known case of Ankylosing Spondylosis.

结局指标

主要结局

Primary Outcome-Reduction in Sandhi shotha (inflammation of joint) by using the measuring tape before and after treatment with Local Application ArthoCan-J100 Lep Powder.

时间窗: 14 days

次要结局

  • Secondary Outcome- Reduction in Sandhi shool (Pain in joints) using the VAS scale before and after treatment with Local Application ArthoCan-J100 Lep Powder.(14 days)

研究者

发起方
Sudhatatva Pharmacy
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Pranesh P Gaikwad

Dr. D.Y.Patil College of Ayurved and Research Centre, Pimpri Pune-18

研究点 (1)

Loading locations...

相似试验